Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Mar
21
2024
FDA Publishes Paper Detailing Actions It Intends to Take Regarding the Uses of AI Across the Medical Product Life Cycle Nelson Mullins
Mar
21
2024
A Psychedelic Use Case for AI Nelson Mullins
Feb
13
2023
Old North State Report – Feb. 13, 2023 Nelson Mullins
Mar
23
2023
FDA Revises Recommendations Regarding Electronic Systems, Records, and Signatures in Clinical Investigations Nelson Mullins
May
30
2023
FDA Studies Foreshadow Potential Changes to Direct-to-Consumer Prescription Drug Advertising Nelson Mullins
May
7
2021
Court Issues a Rare, Severe Discovery Sanction: The Path that Led to Default Judgment Nelson Mullins
May
25
2023
FDA Establishes Public Docket Soliciting Comments on Nitrosamine Drug Substance-Related Impurities Nelson Mullins
Jun
16
2023
NEWMOA Releases First-of-its-kind PFAS Regional Draft Model Legislation for Public Comment Nelson Mullins
Mar
19
2022
Gold Dome Report – Legislative Day 31 Nelson Mullins
Jun
20
2022
Transgender Youth and Access to Healthcare Nelson Mullins
Jan
31
2023
Old North State Report – Jan. 30, 2023 Nelson Mullins
Jan
7
2023
CBP Officers at the San Ysidro Port of Entry Seize Over $2 Million Worth of Cocaine U.S. Customs and Border Protection
Oct
24
2021
CBP Issues Withhold Release Order on Tomatoes Produced by Farm in Mexico U.S. Customs and Border Protection
Nov
7
2022
CBP Officers Seize $18.6 Million in Methamphetamine at Laredo Port of Entry U.S. Customs and Border Protection
Sep
24
2022
413 Pounds of Concealed Marijuana Intercepted by Cincinnati CBP U.S. Customs and Border Protection
Sep
1
2021
Considerations for Employers Thinking about COVID-19 Vaccine Mandates Robinson & Cole LLP
Sep
30
2021
Biometric Information Privacy Programs Robinson & Cole LLP
Sep
13
2022
A COVID-19 Laboratory Testing Conviction under EKRA Robinson & Cole LLP
Jun
26
2019
DOJ Enters into $225 Million Settlement with Opioid Manufacturer to Resolve Criminal and Civil Investigations Robinson & Cole LLP
Oct
7
2019
CMS Passes Final Rule Reducing Regulations Burdensome on Health Care Providers Robinson & Cole LLP
Oct
24
2019
Manufacturers are Not Immune to Claims that their Inventions are Patent-Ineligible Robinson & Cole LLP
Nov
7
2019
Medical Prescription Delivered by Drone Robinson & Cole LLP
Apr
15
2021
The Endless Frontier Act: Shifting the Focus from Defense to Offense Robinson & Cole LLP
Jul
27
2021
Connecticut Legislature Passes Act to Help Address the Opioid Epidemic Robinson & Cole LLP
Oct
3
2019
Privacy Tip #210 – HHS Office of Inspector General Issues Fraud Alert for Genetic Testing Scam Targeting Seniors Robinson & Cole LLP
Jun
4
2023
Unanimous Supreme Court Endorses Subjective Belief Standard for False Claims Liability Robinson & Cole LLP
Oct
24
2023
DEA Further Extends COVID-19 Telemedicine Prescribing Flexibilities through December 31, 2024 Robinson & Cole LLP
Feb
3
2022
COVID-19 Vaccine Update – February 2022 Robinson & Cole LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins